Paper39197836
The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding.
Ludwig KC and 17 others. J Am Chem Soc, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding. Papers, record 39197836. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39197836
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Uridine Diphosphate N-Acetylmuramic Acid | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Molecular Structure | |
| Cell Wall | |
| Small Molecule Libraries |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31743648 | Mechanisms of Incorporation for D-Amino Acid Probes That Target Peptidoglycan Biosynthesis. | ACS Chem Biol | 2019 | https://conductscience.org/library/papers/31743648 | PubMed |
| 2 | 20508130 | Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. | Science | 2010 | https://conductscience.org/library/papers/20508130 | PubMed |
| 3 | 34278794 | AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. | J Chem Inf Model | 2021 | https://conductscience.org/library/papers/34278794 | PubMed |
| 4 | 28209898 | Treadmilling by FtsZ filaments drives peptidoglycan synthesis and bacterial cell division. | Science | 2017 | https://conductscience.org/library/papers/28209898 | PubMed |
| 5 | 25941556 | Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria. | ACS Med Chem Lett | 2015 | https://conductscience.org/library/papers/25941556 | PubMed |
| 6 | 36445587 | Quantitative Analysis of Microscopy Data to Evaluate Bacterial Responses to Antibiotic Treatment. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36445587 | PubMed |
| 7 | 29443967 | Peptidoglycan synthesis drives an FtsZ-treadmilling-independent step of cytokinesis. | Nature | 2018 | https://conductscience.org/library/papers/29443967 | PubMed |
| 8 | 27688760 | Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27688760 | PubMed |
| 9 | 16019076 | Polyisoprenoids: structure, biosynthesis and function. | Prog Lipid Res | 2005 | https://conductscience.org/library/papers/16019076 | PubMed |
| 10 | 36445584 | Microscopy-Based Multiwell Assay to Characterize Disturbed Bacterial Morphogenesis Upon Antibiotic Action. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36445584 | PubMed |
| 11 | 22741745 | DCAP: a broad-spectrum antibiotic that targets the cytoplasmic membrane of bacteria. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/22741745 | PubMed |
| 12 | 30006504 | A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30006504 | PubMed |
| 13 | 22291598 | Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus. | PLoS Pathog | 2012 | https://conductscience.org/library/papers/22291598 | PubMed |
| 14 | 32234311 | A Slippery Scaffold: Synthesis and Recycling of the Bacterial Cell Wall Carrier Lipid. | J Mol Biol | 2020 | https://conductscience.org/library/papers/32234311 | PubMed |
| 15 | 29465397 | Molecular coordination of Staphylococcus aureus cell division. | Elife | 2018 | https://conductscience.org/library/papers/29465397 | PubMed |
| 16 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 17 | 28691491 | Peptidoglycan Cross-Linking Preferences of Staphylococcus aureus Penicillin-Binding Proteins Have Implications for Treating MRSA Infections. | J Am Chem Soc | 2017 | https://conductscience.org/library/papers/28691491 | PubMed |
| 18 | 7096347 | Dolichol metabolism in rat liver. Determination of the subcellular distribution of dolichyl phosphate and its site and rate of de novo biosynthesis. | J Biol Chem | 1982 | https://conductscience.org/library/papers/7096347 | PubMed |
| 19 | 36947615 | Inhibition of peptidoglycan synthesis is sufficient for total arrest of staphylococcal cell division. | Sci Adv | 2023 | https://conductscience.org/library/papers/36947615 | PubMed |
| 20 | 8119922 | Isoprenoid biosynthesis in rat liver mitochondria. Studies on farnesyl pyrophosphate synthase and trans-prenyltransferase. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8119922 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41083887 | Bacterial cell envelope-targeting antibiotics. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/41083887 | PubMed |
| 41083642 | Novel antimicrobial 3-phenyl-4-phenoxypyrazole derivatives target cell wall lipid intermediates with low mammalian cytotoxicity. | Sci Rep | 2025 | https://conductscience.org/library/papers/41083642 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39197836
GET https://conductscience.org/api/papers/v1/39197836/references?page=2